Patents by Inventor Sebastian TROUSIL

Sebastian TROUSIL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
    Publication number: 20240122959
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Application
    Filed: December 18, 2023
    Publication date: April 18, 2024
    Inventors: Avak KAHVEJIAN, Alexandra Sophie De Boer, Nicholas McCartney Plugis, Erica Gabrielle Weinstein, Sebastian Trousil, Morag Helen Stewart, Ki Young Paek, Catherine Cifuentes-Rojas
  • Compositions comprising circular polyribonucleotides and uses thereof
    Patent number: 11844759
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Grant
    Filed: November 16, 2022
    Date of Patent: December 19, 2023
    Assignee: Flagship Pioneering Innovations VI, LLC
    Inventors: Avak Kahvejian, Alexandra Sophie De Boer, Nicholas McCartney Plugis, Erica Gabrielle Weinstein, Sebastian Trousil, Morag Helen Stewart, Ki Young Paek, Catherine Cifuentes-Rojas
  • COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
    Publication number: 20230201241
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Application
    Filed: November 16, 2022
    Publication date: June 29, 2023
    Inventors: Avak Kahvejian, Alexandra Sophie De Boer, Nicholas McCartney Plugis, Erica Gabrielle Weinstein, Sebastian Trousil, Morag Helen Stewart, Ki Young Paek, Catherine Cifuentes-Rojas
  • COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
    Publication number: 20230070937
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Application
    Filed: August 30, 2022
    Publication date: March 9, 2023
    Inventors: Avak Kahvejian, Alexandra Sophie De Boer, Nicholas McCartney Plugis, Erica Gabrielle Weinstein, Sebastian Trousil, Morag Helen Stewart, Ki Young Paek, Catherine Cifuentes-Rojas
  • Compositions comprising circular polyribonucleotides and uses thereof
    Patent number: 11458156
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: October 4, 2022
    Assignee: Flagship Pioneering Innovations VI, LLC
    Inventors: Alexandra Sophie De Boer, Avak Kahvejian, Nicholas McCartney Plugis, Erica Gabrielle Weinstein, Sebastian Trousil, Morag Helen Stewart, Ki Young Paek, Catherine Cifuentes-Rojas
  • COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
    Publication number: 20220023331
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Application
    Filed: September 22, 2021
    Publication date: January 27, 2022
    Inventors: Alexandra Sophie DE BOER, Avak KAHVEJIAN, Nicholas McCartney PLUGIS, Erica Gabrielle WEINSTEIN, Sebastian TROUSIL, Morag Helen STEWART, Ki Young PAEK, Catherine CIFUENTES-ROJAS
  • Compositions comprising circular polyribonucleotides and uses thereof
    Patent number: 11160822
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Grant
    Filed: May 6, 2021
    Date of Patent: November 2, 2021
    Assignee: FLAGSHIP PIONEERING INNOVATIONS VI, LLC
    Inventors: Alexandra Sophie De Boer, Avak Kahvejian, Nicholas McCartney Plugis, Erica Gabrielle Weinstein, Sebastian Trousil, Morag Helen Stewart, Ki Young Paek, Catherine Cifuentes-Rojas
  • COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
    Publication number: 20210275565
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Application
    Filed: May 6, 2021
    Publication date: September 9, 2021
    Inventors: Alexandra Sophie DE BOER, Avak KAHVEJIAN, Nicholas McCartney PLUGIS, Erica Gabrielle WEINSTEIN, Sebastian TROUSIL, Morag Helen STEWART, Ki Young PAEK, Catherine CIFUENTES-ROJAS
  • Compositions comprising circular polyribonucleotides and uses thereof
    Patent number: 11058706
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: July 13, 2021
    Assignee: FLAGSHIP PIONEERING INNOVATIONS VI, LLC
    Inventors: Morag Helen Stewart, Catherine Cifuentes-Rojas, Ki Young Paek, Avak Kahvejian, Nicholas McCartney Plugis, Alexandra Sophie De Boer, Erica Gabrielle Weinstein, Sebastian Trousil
  • COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
    Publication number: 20210161938
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Application
    Filed: February 11, 2021
    Publication date: June 3, 2021
    Inventors: Morag Helen STEWART, Catherine CIFUENTES-ROJAS, Ki Young PAEK, Avak KAHVEJIAN, Nicholas McCartney PLUGIS, Alexandra Sophie DE BOER, Erica Gabrielle WEINSTEIN, Sebastian TROUSIL
  • Compositions comprising circular polyribonucleotides and uses thereof
    Patent number: 10953033
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: March 23, 2021
    Assignee: FLAGSHIP PIONEERING INNOVATIONS VI, LLC
    Inventors: Morag Helen Stewart, Catherine Cifuentes-Rojas, Ki Young Paek, Avak Kahvejian, Nicholas McCartney Plugis, Alexandra Sophie De Boer, Erica Gabrielle Weinstein, Sebastian Trousil
  • Tissue oxygen saturation detection and related apparatus and methods
    Patent number: 10799162
    Abstract: A wearable optical device is described for optically detecting parameters of interest within muscle, such as during physical activity or when at rest. The parameters of interest include oxygenation level and/or hemoglobin concentrations in some situations. The detected parameters, such as oxygenation level, may be used to assess physical performance, such as the extent to which the muscle is utilizing aerobic or anaerobic processes. Methods for determining the parameters of interest, such as oxygenation level, from the detected optical signals are also described, and feedback may be provided to a user.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: October 13, 2020
    Assignee: Whoop, Inc.
    Inventors: Daniel Wiese, Alessandro Babini, Sebastian Trousil, Samuel Huberman, Stefan Kalchmair, Pamela G. Anderson
  • COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
    Publication number: 20200306286
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Application
    Filed: December 14, 2018
    Publication date: October 1, 2020
    Inventors: Morag Helen STEWART, Catherine CIFUENTES-ROJAS, Ki Young PAEK, Avak KAHVEJIAN, Nicholas McCartney PLUGIS, Alexandra Sophie DE BOER, Erica Gabrielle WEINSTEIN, Sebastian TROUSIL
  • HER2 polypeptides useful for imaging and monitoring tumors and cancers
    Patent number: 10646600
    Abstract: A method of use of an isolated polypeptide conjugated with a radionuclide, wherein the isolated polypeptide binds specifically to HER2, or a variant thereof is described. The method is for monitoring the response to HSP90 inhibition and comprises the use of the isolated polypeptide conjugated with 18F. The application also describes the use of an isolated polypeptide conjugated with 18F, wherein the isolated polypeptide binds specifically to HER2 or variants thereof, as an imaging agent to monitor uptake thereof to measure HSP90 inhibition.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: May 12, 2020
    Assignees: IMPERIAL INNOVATIONS LIMITED, GE HEALTHCARE LIMITED
    Inventors: Duncan Robert R. Hiscock, Eric Aboagye, Peter Iveson, Quang-De Nguyen, Susan Hoppmann, Sebastian Trousil, Maciej Kaliszczak, Giampaolo Tomasi
  • COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
    Publication number: 20190307785
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.
    Type: Application
    Filed: June 11, 2019
    Publication date: October 10, 2019
    Inventors: Morag Helen STEWART, Catherine CIFUENTES-ROJAS, Ki Young PAEK, Avak KAHVEJIAN, Nicholas McCartney PLUGIS, Alexandra Sophie DE BOER, Erica Gabrielle WEINSTEIN, Sebastian TROUSIL
  • TISSUE OXYGEN SATURATION DETECTION AND RELATED APPARATUS AND METHODS
    Publication number: 20190099116
    Abstract: A wearable optical device is described for optically detecting parameters of interest within muscle, such as during physical activity or when at rest. The parameters of interest include oxygenation level and/or hemoglobin concentrations in some situations. The detected parameters, such as oxygenation level, may be used to assess physical performance, such as the extent to which the muscle is utilizing aerobic or anaerobic processes. Methods for determining the parameters of interest, such as oxygenation level, from the detected optical signals are also described, and feedback may be provided to a user.
    Type: Application
    Filed: August 31, 2018
    Publication date: April 4, 2019
    Applicant: Dynometrics Inc. d/b/a Humon
    Inventors: Daniel Wiese, Alessandro Babini, Sebastian Trousil, Samuel Huberman, Stefan Kalchmair, Pamela G. Anderson
  • Tissue oxygen saturation detection and related apparatus and methods
    Patent number: 10092228
    Abstract: A wearable optical device is described for optically detecting parameters of interest within muscle, such as during physical activity or when at rest. The parameters of interest include oxygenation level and/or hemoglobin concentrations in some situations. The detected parameters, such as oxygenation level, may be used to assess physical performance, such as the extent to which the muscle is utilizing aerobic or anaerobic processes. Methods for determining the parameters of interest, such as oxygenation level, from the detected optical signals are also described, and feedback may be provided to a user.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: October 9, 2018
    Assignee: Dynometrics Inc.
    Inventors: Daniel Wiese, Alessandro Babini, Sebastian Trousil, Samuel Huberman, Stefan Kalchmair, Pamela G. Anderson
  • TISSUE OXYGEN SATURATION DETECTION AND RELATED APPARATUS AND METHODS
    Publication number: 20180249937
    Abstract: A wearable optical device is described for optically detecting parameters of interest within muscle, such as during physical activity or when at rest. The parameters of interest include oxygenation level and/or hemoglobin concentrations in some situations. The detected parameters, such as oxygenation level, may be used to assess physical performance, such as the extent to which the muscle is utilizing aerobic or anaerobic processes. Methods for determining the parameters of interest, such as oxygenation level, from the detected optical signals are also described, and feedback may be provided to a user.
    Type: Application
    Filed: May 4, 2018
    Publication date: September 6, 2018
    Applicant: Dynometrics Inc. d/b/a Humon
    Inventors: Daniel Wiese, Alessandro Babini, Sebastian Trousil, Samuel Huberman, Stefan Kalchmair, Pamela G. Anderson
  • USE OF HER2 BINDERS
    Publication number: 20160144062
    Abstract: A method of use of an isolated polypeptide conjugated with a radionuclide, wherein the isolated polypeptide binds specifically to HER2, or a variant thereof is described. The method is for monitoring the response to HSP90 inhibition and comprises the use of the isolated polypeptide conjugated with 18F. The application also describes the use of an isolated polypeptide conjugated with 18F, wherein the isolated polypeptide binds specifically to HER2 or variants thereof, as an imaging agent to monitor uptake thereof to measure HSP90 inhibition.
    Type: Application
    Filed: June 24, 2014
    Publication date: May 26, 2016
    Inventors: Ducan Robert R. HISCOCK, Eric Aboagye, Peter IVESON, Quang-De NGUYEN, Susan HOPPMANN, Sebastian TROUSIL, Maciej KALISZCZAK, Giampaolo TOMASI